Mild cognitive impairment: improving predictive prognosis

November 18, 2023
< 1 mins

Category: Published research
Product: NeuroQuant
Disease: Mild cognitive impairment

Mild Cognitive Impairment: Baseline and Longitudinal Structural MR Imaging Measures Improve Predictive Prognosis

To assess whether single-time-point and longitudinal volumetric magnetic resonance (MR) imaging measures provide predictive prognostic information in patients with amnestic mild cognitive impairment (MCI). Radiology, June 2011.

[button]Download[/button]

Topic: Published research

More Resources

02/25/2026

Cortechs.ai Announces MFDS (KFDA) Approval of Global-Leading NeuroQuant® V5 Platform in South Korea

MFDS approves NeuroQuant® V5 in South Korea, expanding AI-driven volumetric neuroimaging and clinical decision support.

Cortechs.ai news, Industry news, Product updates

02/24/2026

Financial Conflict Of Interest Policy Applicable To NIH Awards

Product updates

02/20/2026

NeuroQuant® PET: FDA 510(k)-Pending Advancement in Molecular Dementia Imaging

FDA 510(k)-Pending NeuroQuant® PET delivers automated, standardized quantification for amyloid, tau, and FDG imaging in dementia care.

Blogs, Product updates

02/19/2026

How Cortechs.ai Protects ePHI: HIPAA‑Aligned Controls—and Beyond

Cortechs.ai’s HIPAA-aligned, defense-in-depth security safeguards ePHI across AI workflows—exceeding baseline compliance standards.

Blogs

02/11/2026

NeuroQuant Normative Database: Advancing Age‑ and Sex‑Specific Brain Volumetry

Learn how the latest updates to the NeuroQuant normative database white paper strengthen age- and sex-specific brain volumetry and enhance clinical confidence.

Blogs

02/06/2026

NeuroQuant Normative Database: A Standard for Age- and Sex-Specific Brain Volumetry

Whitepaper: How Cortechs.ai’s normative database was created to accurately compare an individual’s brain structure volume to a healthy population.

Our solutions

Our solutions

About

Support

Resources